AstraZeneca spins out early-stage R&D for antibiotic compoundsAstraZeneca is creating a standalone subsidiary to work exclusively on early-stage antibiotics research and development, the company has announced.…
Immune checkpoint inhibitors bring new hope to cancer patients PD-1 and PD-L1 inhibitors induce a higher response rate across a wider range of tumours than other immunotherapies.…
Q&A: Ensuring vaccine safety is no easy task Patrick LF Zuber, group leader for global vaccine safety at the World Health Organization, talks about vaccine safety, the Ebola vaccine and new vaccines in the pipeline.…
Phase II clinical trials for Ebola vaccine planned for early 2015Experts involved in the organisation of clinical research on Ebola vaccines intend to move to randomised controlled phase II trials in early 2015.…
Potential role for benralizumab in COPD patients with eosinophilia Benralizumab therapy led to a numerical, albeit not statistically significant, improvement in COPD exacerbations and lung function compared with placebo.…
